1.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559
2.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
3.
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
by HARRAP, Stephen B
Hypertension (Dallas, Tex. 1979), 2003, Vol.42 (3), p.297-303
4.
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in a...
by Boyd, M A
The Lancet (British edition), 2013, Vol.381 (9883), p.2091-2099
Filter electronic articles 4 Hits
Remove Filters
- Subjects
- Medical Sciences
- Science & Technology (4)
- Treatment Outcome
- more ...
- Adult
- Male (4)
- Life Sciences & Biomedicine (4)
- Biological And Medical Sciences (4)
- Female (4)
- Humans (4)
- Middle Aged (3)
- Blood Pressure (3)
- Cholesterol (3)
- Blood And Lymphatic Vessels (2)
- Cardiology. Vascular System (2)
- Cardiovascular Disease (2)
- Atherosclerosis (2)
- Anticholesteremic Agents - Admin... (2)
- Adolescent (2)
- Aged (2)
- Amides (2)
- less ...